Scott T. Reents, an officer at AbbVie Inc., is set to sell 14,140 shares of the company's common stock on February 23, 2024. The shares, valued at approximately $2,509,130.78, were acquired on the same day through the exercise of stock options as part of compensation from the issuer. This transaction follows a period where no significant sales activity was reported by Reents in the past three months.

Scott T. Reents, an officer at AbbVie Inc., is set to sell 14,140 shares of the company's common stock on February 23, 2024. The shares, valued at approximately $2,509,130.78, were acquired on the same day through the exercise of stock options as part of compensation from the issuer. This transaction follows a period where no significant sales activity was reported by Reents in the past three months.